Compassionate, Cash-Rich Pharmaceutical Companies Prepare for Rocky Road Ahead
Compassionate, Cash-Rich Pharmaceutical Companies Prepare for Rocky Road Ahead
SUGAR LAND--December 3, 2010--Researched by Industrial Info Resources (Sugar Land, Texas)--The Pharmaceutical Industry has observed major changes over the past year, with performance being affected by factors such as listless prescription trends and escalating generic competition. Big Pharma's novel products are not expected to generate the same level of profit as current products that are losing patent protection. With revenue growth becoming stagnant, companies have been resorting to cost-cutting, share repurchasing, cash conservation, and mergers and acquisitions to drive bottom-line growth.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.